ABIVAX (EPA:ABVX) Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Transparency directive : regulatory news
08/05/2024 08:31
source : webdisclosure.com